| Delivery technologies for cancer immunotherapy RS Riley, CH June, R Langer, MJ Mitchell Nature reviews Drug discovery 18 (3), 175-196, 2019 | 1847 | 2019 |
| Gold nanoparticle‐mediated photothermal therapy: applications and opportunities for multimodal cancer treatment RS Riley, ES Day Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9 (4), e1449, 2017 | 735 | 2017 |
| Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy JR Melamed, RS Edelstein, ES Day ACS nano 9 (1), 6-11, 2015 | 564 | 2015 |
| Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus–unrelated head and neck cancer: a multicenter, phase II trial R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, ... Clinical Cancer Research 26 (19), 5140-5152, 2020 | 216 | 2020 |
| Wiley interdiscip RS Riley, ES Day Rev.: Nanomed. Nanobiotechnol 9 (4), 1449, 2017 | 179 | 2017 |
| Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti–PD-1 resistance in head and neck cancer L Zhou, T Mudianto, X Ma, R Riley, R Uppaluri Clinical Cancer Research 26 (1), 290-300, 2020 | 176 | 2020 |
| Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening PPG Guimaraes, R Zhang, R Spektor, M Tan, A Chung, MM Billingsley, ... Journal of controlled release 316, 404-417, 2019 | 132 | 2019 |
| Ionizable lipid nanoparticles for in utero mRNA delivery RS Riley, MV Kashyap, MM Billingsley, B White, MG Alameh, SK Bose, ... Science advances 7 (3), eaba1028, 2021 | 121 | 2021 |
| Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy AJ Mukalel, RS Riley, R Zhang, MJ Mitchell Cancer letters 458, 102-112, 2019 | 106 | 2019 |
| Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods MM Billingsley, RS Riley, ES Day PloS one 12 (5), e0177592, 2017 | 69 | 2017 |
| Frizzled7 antibody‐functionalized nanoshells enable multivalent binding for Wnt signaling inhibition in triple negative breast cancer cells RS Riley, ES Day Small 13 (26), 1700544, 2017 | 67 | 2017 |
| Advances in targeted nanotherapeutics: from bioconjugation to biomimicry DM Valcourt, J Harris, RS Riley, M Dang, J Wang, ES Day Nano research 11, 4999-5016, 2018 | 64 | 2018 |
| Using gold nanoparticles to disrupt the tumor microenvironment: an emerging therapeutic strategy JR Melamed, RS Riley, DM Valcourt, ES Day Acs Nano 10 (12), 10631-10635, 2016 | 61 | 2016 |
| Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE) H Parhiz, JS Brenner, PN Patel, TE Papp, H Shahnawaz, Q Li, R Shi, ... Journal of Controlled Release 344, 50-61, 2022 | 57 | 2022 |
| Evaluating the mechanisms of light-triggered siRNA release from nanoshells for temporal control over gene regulation RS Riley, MN Dang, MM Billingsley, B Abraham, L Gundlach, ES Day Nano letters 18 (6), 3565-3570, 2018 | 55 | 2018 |
| Evaluating nanoshells and a potent biladiene photosensitizer for dual photothermal and photodynamic therapy of triple negative breast cancer cells RS Riley, RK O’sullivan, AM Potocny, J Rosenthal, ES Day Nanomaterials 8 (9), 658, 2018 | 42 | 2018 |
| Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes PPG Guimaraes, M Tan, T Tammela, K Wu, A Chung, M Oberli, K Wang, ... Journal of controlled release 290, 75-87, 2018 | 41 | 2018 |
| Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy CG Figueroa-Espada, S Hofbauer, MJ Mitchell, RS Riley Advanced Drug Delivery Reviews 160, 244-261, 2020 | 40 | 2020 |
| Photochemotherapeutic properties of a linear tetrapyrrole palladium (II) complex displaying an exceptionally high phototoxicity index AM Potocny, RS Riley, RK O’Sullivan, ES Day, J Rosenthal Inorganic chemistry 57 (17), 10608-10615, 2018 | 34 | 2018 |
| Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a R Goyal, CH Kapadia, JR Melamed, RS Riley, ES Day Cellular and molecular bioengineering 11, 383-396, 2018 | 33 | 2018 |
